• HOME

  • ABOUT

  • PORTFOLIO

    • Fund IV
    • Fund III
    • Fund II
    • Historical
  • _

  • _

  • TEAM.

  • TEAM

  • NEWS

  • CONTACT

  • More

    Use tab to navigate through the menu items.

    A L T I T U D E

    Altitude Life Science Ventures

    Life Science Ventures

    Tessera Therapeutics
    Tessera Therapeutics

    Pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source

    Generate Biomedicines
    Generate Biomedicines

    Developing a machine learning-powered platform can rapidly invent new drugs across a wide range of protein modalities and previously undiscoverable protein therapeutics

    Altos Labs
    Altos Labs

    Focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine

    Ansa Biotechnologies
    Ansa Biotechnologies

    Creating a next-generation enzymatic DNA synthesis platform

    Ring Therapeutics
    Ring Therapeutics

    Developing first-in-class gene therapies, Anellovector™ therapies, using a novel viral vector platform based on its groundbreaking work on the human commensal virome

    Laronde Bio
    Laronde Bio

    Creating endless RNA (eRNA™) —a new class of programmable medicines capable of expressing therapeutic proteins inside the body.

    Mozart Therapeutics
    Mozart Therapeutics

    Developing CD8 T cell immune modulators for the treatment of autoimmune diseases

    1/1